Pharmaceutical

Chugai and Gero link on antibody drugs for age-related conditions

Chugai signed a joint research and licencing agreement with Singapore-based biotechnology firm Gero to create new antibody drug candidates

Jul 9, 2025 - 06:00
Chugai and Gero link on antibody drugs for age-related conditions
Chugai signed a joint research and licencing agreement with Singapore-based biotechnology firm Gero to create new antibody drug candidates
Read the original article

Tags:

Previous Article

Swissmedic approves IFINWIL for children with high-risk neuroblastoma

Next Article

Leading medical groups sue RFK Jr and HHS over ‘hostile’ vaccine policies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

SK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccines

SK bioscience and Sanofi expand agreement for pneumococ...

Dec 25, 2024

Biosyngen’s liver cancer therapy receives fast track designation

Biosyngen’s liver cancer therapy receives fast track de...

Feb 2, 2024

Travere signs $120m licensing deal with Renalys for sparsentan in Asia

Travere signs $120m licensing deal with Renalys for spa...

Jan 27, 2024